Evidence & Literature

The Evidence-Tier System

Patient-facing resources that recommend interventions have an obligation to communicate the strength of evidence behind each recommendation. The three-tier system used throughout Still You and this website was designed for transparency without overwhelming patients who are already experiencing cognitive fatigue.

The rationale for this system: patients will seek recovery tools regardless of whether clinicians provide guidance. The choice is not between patients using these tools and patients not using them. The choice is between patients navigating the landscape with transparent evidence ratings and patients navigating it with marketing claims. The tier system positions the clinician as a guide rather than a gatekeeper.

The Emotional Impact of Neurosurgery

The core claim of this framework — that emotional recovery after neurosurgery is widespread, clinically significant, and systematically under-addressed — rests on a substantial evidence base.

Prevalence and Scope

Jenkins and colleagues (2016) examined emotional and behavioral changes following brain tumor resection, finding approximately 60% prevalence with persistence in most cases. Changes included irritability, emotional lability, personality shifts, and social withdrawal. Notably, many of these changes were identified by caregivers rather than patients, suggesting that patient self-report alone underestimates prevalence.

Zamanipoor Najafabadi and colleagues (2020) followed meningioma patients for up to nine years and documented psychosocial deficits that standard neurosurgical follow-up protocols did not detect. This study is particularly important because meningiomas are typically classified as “benign” — yet the psychosocial impact persisted for nearly a decade post-surgery.

Heffernan and colleagues (2023) studied quality of life after surgery for lower-grade gliomas and found sustained reductions across cognitive, emotional, and social domains — even after successful tumor control. This suggests an ongoing emotional burden that persists well beyond the acute surgical recovery period.

Samman and colleagues (2024), in a comprehensive scoping review, confirmed that emotional and behavioral disturbances are pervasive following brain tumor treatment, affecting domains from social cognition to affective regulation and persisting well beyond the acute post-operative period.

Neuroanatomical Basis of Emotional Change

Lemaitre and colleagues (2021) used voxel-based lesion-symptom mapping to demonstrate that personality changes after tumor resection correlate with specific anatomical locations, with prefrontal and insular involvement conferring particular risk for emotional reactivity and social behavior changes. Campanella and colleagues (2015) showed that surgery produces acute effects on emotion and cognition that emerge independently of tumor progression. Motomura and colleagues (2019) confirmed that stimulation of the anterior insular cortex during awake neurosurgery directly affects emotion recognition, providing neuroanatomical evidence that emotional processing circuits are vulnerable during surgical intervention.

Herbet and Moritz-Gasser (2019) emphasized that emotional circuits are rarely mapped with the same rigor applied to motor and language pathways during surgery, despite their profound impact on patient experience. Together, these studies confirm that post-surgical emotional changes have identifiable neurobiological substrates — they are not adjustment reactions or psychological weakness.

Identity Disruption

Cassimjee and colleagues (2025) studied identity reconstruction in patients following deep brain stimulation for Tourette syndrome, identifying “Transformation: (Re)constructing the self in context after DBS” as a major theme. Patients described not recognizing themselves and needing 12–24 months to reintegrate their new neurological reality with their prior sense of self. Wilt and colleagues (2021) further documented personality trait shifts in DBS patients, and Pugh (2020) argued that these changes require a more nuanced clinical and ethical framework than current informed consent processes provide.

Identity disruption is not captured by mood measures, functional scales, or cognitive assessments, yet patients consistently identify it as among their most distressing experiences. It has neurobiological substrates, and treating it as a purely psychological phenomenon underestimates its depth and persistence.

Caregiver Impact

Guldager and colleagues (2023), in a systematic review, found that caregivers of brain tumor patients experience significant unmet needs across informational, emotional, and practical domains, with emotional burden often persisting longer than the patient's acute recovery phase. Catling and colleagues (2022) documented that caregivers of partners with acquired brain injury experience a complex form of grief — mourning the person their partner was before injury while simultaneously adapting to a new relational reality. Giovannetti and colleagues (2015) described this as “ambiguous loss” — the person is physically present but psychologically altered, creating a grief response that lacks social recognition and clinical support. Crooms and colleagues (2022) emphasized that palliative and supportive care approaches for brain tumor patients should include systematic attention to caregiver needs.

Evidence for Recovery Interventions

The following summarizes the evidence base for key interventions recommended in the recovery framework. Full citations and detailed evidence reviews are available in the book's appendices.

Neurobiological Interventions

Sleep optimization (Tier 1): Rasmussen and colleagues (2018) elucidated the role of glymphatic clearance in brain recovery, demonstrating that sleep serves as a critical modulator of waste clearance and neural restoration. Disrupted sleep architecture is both a symptom of neurological injury and a barrier to recovery.

Structured physical activity (Tier 1): Mojtabavi and colleagues (2022), in a systematic review and meta-analysis, established brain-derived neurotrophic factor (BDNF) as a biomarker of neural recovery following stroke, with physical activity as a primary driver of BDNF elevation. Evidence is Tier 1 for mood and neuroplasticity broadly, with growing Tier 2 evidence specific to post-surgical populations.

Omega-3 supplementation (Tier 1–2): Kim (2014) demonstrated neuroprotective properties of DHA through anti-inflammatory and antioxidant mechanisms in brain injury models. DHA and EPA have a strong mechanistic basis and moderate clinical evidence for neurological recovery.

TMS for depression (Tier 1 general / Tier 2 post-surgical): Sheng and colleagues (2023), reviewing evidence for repetitive TMS in stroke rehabilitation, found that rTMS improved neurological function and emotional outcomes through modulation of neuroplasticity and inflammatory pathways. FDA-cleared for treatment-resistant depression, with growing evidence in post-neurosurgical populations. Rezai and colleagues (2016) demonstrated potential applications in TBI populations.

Psychological Interventions

Cognitive behavioral therapy (Tier 1): CBT adapted for neurological populations has strong evidence for managing mood disturbance, catastrophic thinking, and adjustment challenges. Adaptation is key — standard CBT protocols may need modification for patients with cognitive fatigue, processing speed deficits, or memory impairment.

Acceptance and commitment therapy (Tier 2): ACT's emphasis on psychological flexibility and values-based action is well-suited to patients who must accept permanent neurological changes while maintaining engagement with meaningful life activities.

Psychoeducation (Tier 2): Simply telling patients what to expect emotionally — before emotional changes arrive — reduces distress, improves help-seeking behavior, and prevents the catastrophic interpretations that worsen outcomes. This is arguably the highest-yield intervention available because it costs nothing, takes seconds, and changes the patient's entire framework for understanding their experience.

Psychosocial Interventions

Van Nimwegen and colleagues (2023) reviewed psychosocial interventions for stroke patients and found evidence for multidisciplinary rehabilitation approaches that address mood, recovery expectations, coping strategies, emotional processing, values and needs, and self-management — with effective delivery requiring active engagement and ongoing support. Vaishnavi and Rao (2021) provided a comprehensive clinical guide to brain injury rehabilitation integrating neurobiological recovery with psychological and social dimensions, demonstrating the feasibility of multi-dimensional approaches. Their findings support the framework proposed here, though direct evidence in neurosurgical populations remains limited.

Temporal Mismatch

The evidence consistently demonstrates a critical mismatch between post-operative support duration and emotional recovery timelines. Standard neurosurgical follow-up typically provides intensive assessment for 6–12 weeks, then discharges to primary care. Yet Zamanipoor Najafabadi and colleagues documented emotional burden persisting at nine years. Ragoschke-Schumm and colleagues (2015), in a five-year follow-up of hemicraniectomy patients, found that emotional trajectory diverged from functional trajectory — older patients showed improved emotional acceptance even with persistent functional deficits. The implication: post-operative emotional support ends precisely when active emotional recovery begins.

Why Structured Frameworks Matter

The absence of a widely adopted framework for emotional recovery after neurosurgery has practical consequences. Without a shared language, clinicians default to the tools they have (depression screening), patients interpret their experience through the categories available to them (personal failure, mental illness), and caregivers navigate without guidance.

A structured framework does not need to be perfect to be useful. It needs to capture the dimensions of the problem, provide assessment language, suggest intervention targets, and be simple enough to use in a clinical encounter. The three-dimensional model proposed here — neurobiological, psychological, existential — is intended as a starting point for clinical adoption and empirical validation, not a finished product.